WEBINAR
M. Sitges, M. Adamo, P. Lurz, D. Muraru and T. De Potter guide you through understanding combined mitral regurgitation and tricuspid regurgitation in patients with atrial fibrillation.

The Focus Group is committed to fostering the establishment of tricuspid therapies, improving outcomes, and delivering sustainable clinical solutions for complex patients. Discover an overview of the new initiative’s mission and five ongoing working groups dedicated to improving the treatment of patients with tricuspid valve disease
Please fill your email address below to keep tuned.
Learn the reasons behind these groups and how other multidisciplinary teams are working to build alignment in additional topics of uncertainty - such as mitral valve interventions and mechanical circulatory support.